Clinical Trials
6 trialsNCT06760637 2026-05-19
FourLight-3
Pfizer
Phase 3 Active not recruiting
NCT07187726 2026-05-19
PRE-ACT-01
UNICANCER
Phase NA Recruiting
NCT07062965 2026-05-06
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Pfizer
Phase 3 Recruiting
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT05142358 2026-02-02
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
Case Comprehensive Cancer Center
Phase NA Completed
NCT04481113 2026-01-29
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
OHSU Knight Cancer Institute
Phase 1 Completed